Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Clinical trial NCT07225816 · RECRUITING
Trial details
- NCT number
- NCT07225816
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2026-12-13
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.